Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Categories: News

Biorasi Unveils New Website to Drive Sponsor Success with Biotech-Centric Strategies and Modular CRO Solutions

Relaunch puts customized CRO services front and center for today’s Biotech and Biopharma innovators.

AVENTURA, FL / ACCESS Newswire / October 8, 2025 / Biorasi, a leading global full-service contract research organization (CRO), has relaunched its website to reflect a bold new direction: Empowering biotech sponsors with modular clinical trial solutions, AI-powered tools, and a renewed focus on sponsor-centric strategy.

“The future of clinical research belongs to those who can adapt, innovate, and deliver,” said Chris O’Brien, CEO of Biorasi. “Our new website reflects a strategic evolution – one that puts biotech sponsors at the center of smarter, faster, and more flexible trials. It’s a touchstone for the modular solutions and AI-powered tools that will define the next era of clinical success.”

Key updates to the website include:

  • Focused Study Solutions: Critical standalone service offerings deliver the same high-performance features found in Biorasi’s full-service strategies:

    • Study Rescue and Recovery Packages: Designed to salvage struggling clinical trials and restore timelines.

    • Flexible Data Sciences Solutions: Advanced analytics and biostatistics available as standalone services.

    • Specialized Services: Including Quality Assurance, Clinical Monitoring, and Safety & Pharmacovigilance, tailored to sponsor needs.

    • Accelerated Startup Modules: Fast-track solutions for trials requiring rapid market entry.

  • AI-Powered Feasibility: Dynamic clinical site modeling combined with targeted feasibility outreach and enrollment forecasting.

  • New Sponsor Strategy: A sharpened focus on the CRO competencies that matter most: Reliability, Flexibility, and Accessibility.

The redesigned website celebrates Biorasi’s over two decades of industry leadership, clinical trial experience, and operational excellence:

  • Over 200 global studies executed.

  • Five FDA approvals in the past seven years.

  • $150M+ in recovered rescue studies.

  • 6 weeks or less for database go-live.

  • Kickoff Meetings in 10 business days after LOI/WO.

  • 60% repeat business from returning sponsors.

  • Studies conducted in 48 countries, reaching 65% of the global population.

About Biorasi
Biorasi is a global clinical research organization (CRO) that delivers speed-to-market strategies for small to midsized biotech and biopharma sponsors. With over two decades of expertise in running clinical trials across dermatology, oncology, neurology, nephrology, and other key therapeutic areas, Biorasi leverages reliable, flexible, and accessible solutions necessary to succeed in today’s dynamic and evolving clinical trials industry. Contact Biorasi at info@biorasi.com / (786) 388-0700.

SOURCE: Biorasi, LLC

View the original press release on ACCESS Newswire

Staff

Recent Posts

Building Smarter: How Proptech Is Reshaping Canadian Real Estate Development

TORONTO, ONTARIO / ACCESS Newswire / February 28, 2026 / Across Canada's urban centres, a…

2 hours ago

moveBuddha Launches New 100-Point Rating System for Interstate Moving Companies in 2026

moveBuddha, the leading authority on moving company research and consumer protection in the US, today…

2 hours ago

MEWA Launches the First Saudi Water Week Next April to Shape the Future of the Water Sector Regionally and Globally

MEWA Launches the First Saudi Water Week Next April RIYADH, SA / ACCESS Newswire /…

2 hours ago

Pure Canna Organics Revolutionizes Affordable Wellness with Premium CBD Products

BEND, OR / ACCESS Newswire / February 28, 2026 / Pure Canna Organics is redefining…

2 hours ago

Dr. Joel Durinka Establishes New Academic Scholarship to Support Aspiring Physicians and Medical Innovation

BUFFALO, NY / ACCESS Newswire / February 28, 2026 / The Dr. Joel Durinka Scholarship…

2 hours ago